Respimat® re-usable: Information for patients and carers
The day to day use of the Respimat® inhaler remains the same (see the How to Use section). However, changing the Respimat® to become a re-usable inhaler means that there are some important differences to be aware of. The disposable Respimat® is no longer available for new prescriptions.
|Length: ~10.5cm||Length: ~11.5cm|
|One cartridge only.1||
Multiple refill cartridges (up to six).2
|Dose indicator was located on the side of the inhaler with an arrow that went from green to red as doses decreased.1||Dose indicator is located at the bottom of the cartridge and has a large text size with number of doses clearly displayed with white background. This changes to a yellow background when the cartridge has almost been used up and then a red “replacement” arrow when the cartridge is empty.2|
|Once the dose indicator reached the end of the red scale, the Respimat® locked automatically – no more doses could be released. At this point, you could not turn the clear base any further.1||The clear base is automatically released from the inhaler when the cartridge is empty. Your inhaler locks after the labelled number of doses is used. The inhaler then unlocks when you insert a new cartridge and the case is reattached.2|
|No cartridge counter.1||Cartridge counter on the inhaler. There are check boxes on the side of the inhaler that you should tick when a cartridge has been used.2|
|The Respimat® inhaler was more environmentally friendly than pressurised metered dose inhalers (pMDI) as it did not use a propellant, such as hydrofluoroalkane (HFA), which is a greenhouse gas.2||The Respimat® inhaler is more environmentally friendly than pressurised metered dose inhalers (pMDI) as it does not use a propellant, such as hydrofluoroalkane (HFA), which is a greenhouse gas.2 The Respimat® re-usable has the potential to be more environmentally friendly than the disposable inhaler, as there will be less waste due to re-use with up to 6 cartridges.|
Reference 1. Summary of Product Characteristics: Spiriva® Respimat® 2.5 microgram, inhalation solution. March 2018.
Reference 2. Dhand et al 2019. Improving usability and maintaining performance: human-factor and aerosol-performance studies evaluating the new reusable Respimat inhaler. International Journal of COPD. 14 509–523.
NP-UK-100837 V1 | September 2019